WallStSmart

RedCloud Holdings plc Ordinary Shares (RCT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 435% more annual revenue ($258.90M vs $48.40M). ZEPP leads profitability with a -15.5% profit margin vs -110.3%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

RCT

Avoid

28

out of 100

Grade: F

Growth: 6.7Profit: 2.5Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

RCTUndervalued (+77.3%)

Margin of Safety

+77.3%

Fair Value

$4.05

Current Price

$0.70

$3.34 discount

UndervaluedFair: $4.05Overvalued
ZEPPUndervalued (+48.8%)

Margin of Safety

+48.8%

Fair Value

$46.82

Current Price

$18.43

$28.39 discount

UndervaluedFair: $46.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RCT0 strengths · Avg: 0/10

No standout strengths identified

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

RCT4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$39.00M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-16.04M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : RCT

Revenue growth of 11.8% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : RCT

The primary concerns for RCT are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

RCT profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 28/100) and 43.0% revenue growth. RCT offers better value entry with a 77.3% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

RedCloud Holdings plc Ordinary Shares

TECHNOLOGY · SOFTWARE - APPLICATION · USA

RedCloud Holdings plc is an innovative technology company at the forefront of transforming the payment and banking sectors through advanced digital financial solutions. With a strong emphasis on financial inclusivity, RedCloud provides a comprehensive platform that enables seamless real-time transactions for businesses and consumers alike. By harnessing cutting-edge technologies such as blockchain and artificial intelligence, the company delivers secure, scalable, and tailored services that cater to a variety of market demands. As a pivotal player in the expanding digital economy, RedCloud is strategically positioned to leverage the increasing global appetite for efficient and innovative payment solutions, making it an attractive consideration for institutional investors.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?